Editorial Team
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Editorial Team | Published : February 3, 2026 6:13 PM IST
The last five decades have seen a tremendous change in the field of cardiac care. Since the debut of the first balloon angioplasty in 1977 until the present-day image-guided and precision-driven procedures, the history of heart care reflects the development of modern medicine as a whole- gradual towards safer and more customised therapy of patients. This has been a significant journey in India where the country has not only managed to deal with one of the highest burden of cardiovascular disease in the world but they are also becoming a world leader in the field of medical technology.
This development took shape of the main theme of the PRISM-PCI Conclave 2026, which will be organised at Meril Life Sciences academy, in Vapi. The three-day event saw the gathering of nearly 300 interventional cardiologists across India and the globe to analyze that angioplasty which was thought to be a simple process has turned into a complex process and how innovation is transforming patient outcomes.
PRISM is an acronym of Precision Revascularisation based on Innovation-Guided Strategy in the Management of Complex PCI. The idea represents a new dawn in the heart care: nowadays the patients of the heart often have multi-vessel disease, heavy calcification, heart failure, or have to be operated at a much younger age than it used to be in previous decades. Such complexity requires not just technical skills but a clear imaging, physiological evaluation, sophisticated equipment and specific patient-focused, well-thought-out strategy.
According to Dr C. N. Makhale, Interventional Cardiologist, Ruby Hall Clinic, Pune, the future of angioplasty is to understand the disease more, by using imaging and physiology to guide treatment decisions. Each clogged artery has its tale, and accuracy is not merely being cautious, it is being correct. This will enhance safety and consistency as cases are becoming complicated all over the world. He also pointed out that the most moving decisions are made even prior to the initial installation of the piece of equipment and that imaging and physiological analysis can provide a picture not only of what lesions actually need to undergo surgery but also how to tackle them.
In this view, Dr Abhijit Palshikar, a Director of Cardiology, Sahyadri Hospital, Pune, emphasized how the issue of precision has come into the limelight in modern interventional practice. It starts before your contact with the wire. The angiogram cannot provide answers to the questions of what exactly the blockages represent, but imaging and physiology can is it clear that the patient is under a real risk and should be handled using alternative methods?
He said that these tools have changed our perception about coronary disease and have minimised the uncertainty, enhanced safety in procedures as well as provide a more uniform result. At PRISM-pci, it was evident that precision-guided, data-driven decision-making is no longer an option but the core of the standard of cardiology as the complexity of the procedures is constantly increasing.
One of the themes that were repeated during the conclave was the growing presence of India in terms of cardiac innovation in the world. Home-grown technologies in the last 10 years such as sophisticated coronary stents and imaging-guided interventions to transcatheter heart valves have played an important role in providing access to modern cardiac care in the US and globally. This development has minimized reliance on imports and it has placed the Indian clinicians in a position to have technologies which are similar to those in the global standards.
In addition to the devices and methods, another key point that PRISM-PCI highlighted was the aspect of prevention. As the issue of cardiovascular disease spread among younger populations, experts have stressed that even the advanced intervention can save lives, but the long-term outcome will be associated with the early detection, change of the lifestyle, and the maintenance of the public awareness campaigns.
With the end of the concave, PRISM-PCI turned out to be more than a scientific meeting. It was a bigger change in the global healthcare history when not only the cardiac patients of the world are being treated in India, but also, India itself is defining the future of heart care by being innovative, research-driven, and solution-oriented.
Meril is an international medical device manufacturer with its headquarters in India that focuses on promoting healthcare by innovating. Having a solid emphasis on research and development, Meril has provided the latest medtech solutions in over 150 countries and has a well-established international base through subsidiaries in the USA, Brazil, Europe, Asia, Africa, and Australia. Meril has been contributing to the redefinition of the future of healthcare through partnerships, precision technology, and observation of international quality standards.
